Cryoablation Devices market set for 10.26% CAGR growth from 2024-2032, fueled by rising cancer and cardiovascular disease prevalence. TX, UNITED STATES, January 30, 2025 /EINPresswire / -- According ...
LAGUNA HILLS, Calif., April 17, 2025--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment ...
IceCure Medical has reported data from three clinical trials, showcasing the efficacy of its ProSense cryoablation device in the treatment of breast cancer, as the company battles poor financial ...
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the segment of the United States nonvascular interventional radiology device market with ...
Bad Nauheim, Germany - The treatment of atrial fibrillation (AF) with an investigational cryoablation balloon device (Arctic Front, Cryocath) is safe and feasible, but success is limited to patients ...
A reusable breast cancer treatment device created by a group of students at Johns Hopkins University offers a low-cost alternative for women in low-income and low-resource countries. The ...
Medtronic plc won expanded FDA 510(k) approval for its Arctic Front family of cardiac cryoablation catheters for alternative treatment of recurrent symptomatic paroxysmal atrial fibrillation (AF) as ...
Gaithersburg, MD - The FDA's Circulatory System Devices Advisory Panel has voted 8 to 2 in favor of recommending approval of the CryoCor Cryoablation System for the treatment of atrial flutter. Those ...
Agency’s Breakthrough Device Designation Program Allows for Priority Review of Ablation Technology for Ventricular Tachycardia The FDA Breakthrough Device Program, which reflects the FDA’s commitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback